Evaluation of Groin Lymphadenectomy Extent For Metastatic Melanoma

PHASE3CompletedINTERVENTIONAL
Enrollment

634

Participants

Timeline

Start Date

March 2, 2015

Primary Completion Date

October 17, 2024

Study Completion Date

October 17, 2024

Conditions
Metastatic Melanoma to the Groin Lymph Nodes
Interventions
PROCEDURE

Inguinal Lymphadenectomy

PROCEDURE

Ilio-inguinal Lymphadenectomy

Trial Locations (17)

1000

Institute of Oncology Ljubljana, Ljubljana

2060

Melanoma Institute Australia - The Poche Centre, North Sydney

2076

Sydney Adventist Hospital, Sydney

2145

Westmead Hospital, Sydney

2617

Calvary Public Hospital Bruce, Canberra

3000

Peter MacCallum Cancer Centre, Melbourne

4101

Mater Hospital Brisbane, Brisbane

6525

Radboud University Nijmegen Medical Center, Nijmegen

9713

University Medical Center Groningen, Groningen

35128

Veneto Institute of Oncology - IOV, Padua

Unknown

Royal Prince Alfred Hospital, Sydney

Guy's and St Thomas's Hospitals, London

St George's Hospital, London

St Helen's and Knowsley Teaching Hospitals, St Helens

14784-400

Hospital de Câncer de Barretos, Barretos

01508-010

A.C. Camargo Cancer Center, São Paulo

NR4 7UY

Norfolk and Norwich University Hospital, Norwich

All Listed Sponsors
collaborator

Cancer Council New South Wales

OTHER

collaborator

Melanoma Institute Australia

OTHER

lead

Melanoma and Skin Cancer Trials Limited

OTHER

NCT02166788 - Evaluation of Groin Lymphadenectomy Extent For Metastatic Melanoma | Biotech Hunter | Biotech Hunter